SAGE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - SAGE Therapeutics Inc

Watchlist Manager

Watchlist

Price: 8.68 USD Market Closed

Market Cap: $544.9m

	SAGE Therapeutics Inc NASDAQ:SAGE	US
	First Financial Corp NASDAQ:THFF	US
N	Nabati Foods Global Inc CNSX:MEAL	CA
	Akari Therapeutics PLC NASDAQ:AKTX	US
C	Credit Suisse Group AG XHAM:CSX	CH
	Hudson Global Inc NASDAQ:HSON	US

Profitability Summary

SAGE Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Strong 3Y Average Gross Margin

80%

Negative Operating Margin

-430%

Negative 3Y Average Operating Margin

-1 778%

Operating Margin is Increasing

-6 163% > -430%

Negative Net Margin

-428%

Negative 3Y Average Net Margin

-1 727%

Net Margin is Increasing

-5 931% > -428%

Negative Free Cash Flow Margin

-411%

Negative 3Y Average Free Cash Flow Margin

-1 491%

Free Cash Flow Margin is Increasing

-5 391% > -411%

Negative ROE

-60%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-750%

ROIC is Increasing

-762% > -616%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.